Summary: A bio company specializing in new drug development and in vitro diagnostic devicesSummary:Abiocompanyspecializinginnewdrugdevelopmentandinvitrodiagnosticdevices
Target Industries: Pharmaceutical Industry, Bio Industry, Pharmaceutical Quality Control, New Drug Development Support, In Vitro Diagnostic DevicesTargetIndustries:PharmaceuticalIndustry,BioIndustry,PharmaceuticalQualityControl,NewDrugDevelopmentSupport,InVitroDiagnosticDevices
Major Markets/Export Countries: Japan, USAMajorMarkets/ExportCountries:Japan,USA
Certifications/Patents: Designated by the Ministry of Food and Drug Safety as a pharmaceutical quality inspection and clinical trial sample analysis institution, Patent application in progress for NTMD technology, Certified Corporate Research InstituteCertifications/Patents:DesignatedbytheMinistryofFoodandDrugSafetyasapharmaceuticalqualityinspectionandclinicaltrialsampleanalysisinstitution,PatentapplicationinprogressforNTMDtechnology,CertifiedCorporateResearchInstitute
Core Advantages: Business diversification through CMO entry, Preparation for entry into gene therapy and advanced biopharmaceutical CMO, Cost reduction and test time reduction through NTMD and NALF platforms, Profitability expansion through mRNA vaccine quality inspection contract with PfizerCoreAdvantages:BusinessdiversificationthroughCMOentry,PreparationforentryintogenetherapyandadvancedbiopharmaceuticalCMO,CostreductionandtesttimereductionthroughNTMDandNALFplatforms,ProfitabilityexpansionthroughmRNAvaccinequalityinspectioncontractwithPfizer
Introduction
Location
7층, 260 Changnyong-daero, Yeongtong-gu, Suwon, Gyeonggi-do, South Korea